$4.3B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | BMRN Biomarin Pharmaceutical Inc | 6.0M | +68.5% | $345M | 8.1% |
| 2 | NBIX Neurocrine Biosciences Inc | 1.9M | +50.4% | $317M | 7.4% |
| 3 | ABIVAX SA Abivax Sa | 2.3M | +56.6% | $313M | 7.3% |
| 4 | UTHR United Therapeutics Corp Del | 435,000 | +480.0% | $236M | 5.5% |
| 5 | ELVN Enliven Therapeutics Inc | 4.0M | +23.1% | $203M | 4.7% |
| 6 | NRIX Nurix Therapeutics Inc | 8.1M | +23.8% | $195M | 4.6% |
| 7 | BCAX Bicara Therapeutics Inc | 5.2M | −3.2% | $156M | 3.6% |
| 8 | TSHA Taysha Gene Therapies Inc | 19.4M | +7.9% | $132M | 3.1% |
| 9 | ARWR Arrowhead Pharmaceuticals In | 1.6M | −30.8% | $128M | 3.0% |
| 10 | ABT Abbott Laboratories | 1.4M | — | $127M | 3.0% |
| 11 | ZBH Zimmer Biomet Holdings Inc | 1.4M | +636.8% | $121M | 2.8% |
| 12 | IRON Disc Medicine Inc | 1.6M | +121.4% | $113M | 2.6% |
| 13 | GLUE Monte Rosa Therapeutics Inc | 4.6M | +27.7% | $111M | 2.6% |
| 14 | PODD Insulet Corp | 670,000 | +1224.1% | $102M | 2.4% |
| 15 | ASND Ascendis Pharma A/S | 375,000 | — | $100M | 2.3% |
| 16 | AZN Astrazeneca Plc | 450,000 | +350.0% | $85M | 2.0% |
| 17 | SNY Sanofi Sa | 2.0M | +42.9% | $85M | 2.0% |
| 18 | RVMD Revolution Medicines Inc | 450,000 | −81.1% | $84M | 2.0% |
| 19 | BCRX Biocryst Pharmaceuticals Inc | 8.3M | +18.1% | $83M | 1.9% |
| 20 | DYN Dyne Therapeutics Inc | 3.4M | −15.6% | $75M | 1.8% |
| 21 | NKTR Nektar Therapeutics | 1.0M | +250.9% | $70M | 1.6% |
| 22 | GMED Globus Med Inc | 850,000 | +39.2% | $67M | 1.6% |
| 23 | TARS Tarsus Pharmaceuticals Inc | 1.1M | +425.0% | $66M | 1.5% |
| 24 | IMTX Immatics N.V | 6.2M | +0.0% | $63M | 1.5% |
| 25 | TRVI Trevi Therapeutics Inc | 3.1M | +43.1% | $58M | 1.4% |
| 26 | IMCR Immunocore Hldgs Plc | 1.8M | −34.9% | $57M | 1.3% |
| 27 | RGEN Repligen Corp | 400,000 | −56.8% | $55M | 1.3% |
| 28 | BMY Bristol-Myers Squibb Co | 800,000 | −20.0% | $46M | 1.1% |
| 29 | UNIQURE NV Uniqure Nv | 935,000 | +160.4% | $43M | 1.0% |
| 30 | XENE Xenon Pharmaceuticals Inc | 700,000 | +9.4% | $42M | 1.0% |
| 31 | DRUG Bright Minds Biosciences Inc | 545,000 | +10.7% | $38M | 0.9% |
| 32 | MDGL Madrigal Pharmaceuticals Inc | 65,000 | +106.6% | $35M | 0.8% |
| 33 | ALC Alcon Ag | 500,000 | −37.5% | $34M | 0.8% |
| 34 | MYGN Myriad Genetics Inc | 5.7M | +248.0% | $33M | 0.8% |
| 35 | RAPP Rapport Therapeutics Inc | 730,000 | −49.2% | $30M | 0.7% |
| 36 | CBIO Crescent Biopharma Inc. | 1.6M | +8.7% | $29M | 0.7% |
| 37 | GEHC Ge Healthcare Technologies I | 450,000 | +80.0% | $29M | 0.7% |
| 38 | INSM Insmed Inc | 250,000 | — | $27M | 0.6% |
| 39 | VKTX Viking Therapeutics Inc | 680,000 | −25.6% | $27M | 0.6% |
| 40 | BBNX Beta Bionics Inc | 1.6M | −27.7% | $25M | 0.6% |
| 41 | REGN Regeneron Pharmaceuticals | 40,000 | +0.0% | $25M | 0.6% |
| 42 | SLDB Solid Biosciences Inc | 2.2M | −56.8% | $22M | 0.5% |
| 43 | ANRO Alto Neuroscience Inc | 785,000 | −62.0% | $21M | 0.5% |
| 44 | TRAX First Tracks Biotherapeutics | 1.0M | — | $20M | 0.5% |
| 45 | LXEO Lexeo Therapeutics Inc | 4.3M | −3.5% | $20M | 0.5% |
| 46 | SVRA Savara Inc | 2.7M | +4.6% | $17M | 0.4% |
| 47 | DMRA Damora Therapeutics Inc | 575,000 | −4.2% | $15M | 0.3% |
| 48 | SGP Spyglass Pharma Inc | 670,000 | +0.5% | $15M | 0.3% |
| 49 | TECX Tectonic Therapeutic Inc | 425,000 | +29.6% | $15M | 0.3% |
| 50 | AVTX Avalo Therapeutics Inc | 775,000 | — | $14M | 0.3% |